Clinical Trials in Minneapolis

Showing 4321-4340 of 14,456 trials

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

NCT04578912

The study will examine whether combining Comprehensive Behavioral Intervention for Tics (CBIT) with inhibition of the supplementary motor area (SMA) using transcranial magnetic stimulation (TMS) normalizes activity in the SMA-connected circuits, improves tic suppression ability, and enhances CBIT outcomes in young people with tic disorder. The study will also examine different TMS dosing strategies.

Tic DisordersTicsTic, Motor+4 more

University of Minnesota50 participantsStarted Nov 2020

Minneapolis, Minnesota, United States

COMPLETEDPhase 1< 1 mile

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

NCT05441501

The purpose of this study is to determine recommended phase 2 dose(s) (RP2Ds) of JNJ-80038114 in Part 1 (dose escalation) and to determine the safety at the RP2D(s) in Part 2 (dose expansion).

Prostatic Neoplasms

Janssen Research & Development, LLC39 participantsStarted Nov 2022

Minneapolis, Minnesota, United States • Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States +3 more locations

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Find Trials by Condition in Minneapolis

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

A Study Evaluating ANV600 Single Agent or in Combination with Pembrolizumab in Participants with Advanced Solid Tumors (EXPAND-1)

Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer